spectinomycin 🐶 Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |
| Stem definition | Drug id | CAS RN |
|---|---|---|
| antibiotics, produced by Streptomyces strains | 2468 | 1695-77-8 |
Description:
| Molecule | Description |
|---|---|
|
Synonyms:
|
An antibiotic produced by Streptomyces spectabilis. It is active against gram-negative bacteria and used for the treatment of GONORRHEA.
Legend: OFP - off patent OFM - off market ONP - on patent |
Drug dosage:
| Dose | Unit | Route |
|---|---|---|
| 3 | g | P |
ADMET properties:
| Property | Value | Reference |
|---|---|---|
| BDDCS (Biopharmaceutical Drug Disposition Classification System) | 3 | Benet LZ, Broccatelli F, Oprea TI |
| S (Water solubility) | 7.50 mg/mL | Benet LZ, Broccatelli F, Oprea TI |
| EoM (Fraction excreted unchanged in urine) | 70 % | Benet LZ, Broccatelli F, Oprea TI |
| MRTD (Maximum Recommended Therapeutic Daily Dose) | 200.69 µM/kg/day | Contrera JF, Matthews EJ, Kruhlak NL, Benz RD |
| Vd (Volume of distribution) | 0.13 L/kg | Lombardo F, Berellini G, Obach RS |
| CL (Clearance) | 0.99 mL/min/kg | Lombardo F, Berellini G, Obach RS |
| t_half (Half-life) | 1.80 hours | Lombardo F, Berellini G, Obach RS |
Approvals:
| Date | Agency | Company | Orphan |
|---|---|---|---|
| June 30, 1971 | FDA | PFIZER |
FDA Adverse Event Reporting System (Female)
None
FDA Adverse Event Reporting System (Male)
None
FDA Adverse Event Reporting System (Geriatric)
None
FDA Adverse Event Reporting System (Pediatric)
None
Pharmacologic Action:
| Source | Code | Description |
|---|---|---|
| ATC | J01XX04 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE OTHER ANTIBACTERIALS Other antibacterials |
| MeSH PA | D000900 | Anti-Bacterial Agents |
| MeSH PA | D000890 | Anti-Infective Agents |
| CHEBI has role | CHEBI:33281 | antibiotics |
| CHEBI has role | CHEBI:36047 | antibacterial drugs |
Drug Use | Suggest Off label Use Form| |View source of the data|
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Gonorrhea | indication | 15628003 | DOID:7551 |
| Acute gonococcal cervicitis | indication | 20943002 | DOID:10615 |
| Acute gonococcal urethritis | indication | 29864006 | |
| Gonorrhea of rectum | indication | 42746002 | |
| Disseminated Gonococcal Infection | indication |
🐶 Veterinary Drug Use
| Species | Use | Relation |
|---|---|---|
| Cattle | Respiratory disease associated with Mannheimia haemolytica | Indication |
| Cattle | Respiratory disease associated with Pasteurella multocida | Indication |
| Cattle | Respiratory disease associated with Histophilus somni | Indication |
| Chickens | Infectious synovitis caused by Mycoplasma synoviae | Indication |
| Chickens | Prevention or control of losses caused by CRD associated with M gallisepticum (PPLO) | Indication |
| Dogs | Infectious diarrhea and gastroenteritis | Indication |
| Dogs | Infections caused by gram-negative and gram-positive organisms | Indication |
| Swine | Infectious bacterial enteritisassociated with Escherichia coli | Indication |
| Turkeys | Prevention of mortality associated with Arizona group infection | Indication |
| Turkeys | Chronic respiratory disease (CRD) associated with Escherichia coli | Indication |
| Turkeys | Control of airsacculitis associated with M meleagridis | Indication |
🐶 Veterinary products
| Product | Applicant | Ingredients |
|---|---|---|
| Spectinomycin Tablet and Injection | Zoetis Inc. | 1 |
| Spectam Scour Halt | Huvepharma EOOD | 1 |
| SpectoGard Water Soluble Powder | Bimeda Animal Health Limited | 1 |
| Spectam Injectable | Huvepharma EOOD | 1 |
| Spectinomycin Oral Liquid | Zoetis Inc. | 1 |
| L-S 50 Water Soluble Powder | Zoetis Inc. | 2 |
| Spectam Injectable | Elanco US Inc. | 1 |
| Spectam Tablets | Bimeda Animal Health Limited | 1 |
| Adspec Sterile Solution | Zoetis Inc. | 1 |
| PROSPEC Injectable, Spectinomycin Injectable | Zoetis Inc. | 1 |
| Lincomycin - Spectinomycin | Phibro Animal Health Corp. | 2 |
| Spectogard Scour-Chek | Bimeda Animal Health Limited | 1 |
| SpecLinx-50 | Bimeda Animal Health Limited | 2 |
| Lincomycin-Spectinomycin Water Soluble Powder | Huvepharma EOOD | 2 |
Acid dissociation constants calculated using MoKa v3.0.0
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 13.28 | acidic |
| pKa2 | 9.94 | Basic |
| pKa3 | 5.96 | Basic |
Orange Book patent data (new drug applications)
None
Orange Book exclusivity data (new drug applications)
None
Bioactivity Summary:
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| 30S ribosomal protein S12 | Cytosolic other | WOMBAT-PK |
External reference:
| ID | Source |
|---|---|
| 4018092 | VUID |
| N0000179731 | NUI |
| D08526 | KEGG_DRUG |
| 22189-32-8 | SECONDARY_CAS_RN |
| 4018092 | VANDF |
| 4019932 | VANDF |
| C0001268 | UMLSCUI |
| CHEBI:146260 | CHEBI |
| SCM | PDB_CHEM_ID |
| CHEMBL1167 | ChEMBL_ID |
| CHEMBL3989571 | ChEMBL_ID |
| CHEMBL1200407 | ChEMBL_ID |
| DB00919 | DRUGBANK_ID |
| D000198 | MESH_DESCRIPTOR_UI |
| 15541 | PUBCHEM_CID |
| 11127 | IUPHAR_LIGAND_ID |
| 1429 | INN_ID |
| 93AKI1U6QF | UNII |
| 10862 | RXNORM |
| 4127 | MMSL |
| 5505 | MMSL |
| d00372 | MMSL |
| 002790 | NDDF |
| 004865 | NDDF |
| 24809001 | SNOMEDCT_US |
| 372882007 | SNOMEDCT_US |
| 86066003 | SNOMEDCT_US |
| 64058-48-6 | SECONDARY_CAS_RN |
Pharmaceutical products:
None